Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus

OBJECTIVE: Recently approved direct acting antivirals provide transformative therapies for chronic hepatitis C virus (HCV) infection. The major clinical challenge remains to identify the undiagnosed patients worldwide, many of whom live in low-income and middle-income countries, where access to nucl...

Descripción completa

Detalles Bibliográficos
Autores principales: Llibre, Alba, Shimakawa, Yusuke, Mottez, Estelle, Ainsworth, Shaun, Buivan, Tan-Phuc, Firth, Rick, Harrison, Elliott, Rosenberg, Arielle R, Meritet, Jean-François, Fontanet, Arnaud, Castan, Pablo, Madejón, Antonio, Laverick, Mark, Glass, Allison, Viana, Raquel, Pol, Stanislas, McClure, C Patrick, Irving, William Lucien, Miele, Gino, Albert, Matthew L, Duffy, Darragh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176522/
https://www.ncbi.nlm.nih.gov/pubmed/29615488
http://dx.doi.org/10.1136/gutjnl-2017-315783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176522/
https://www.ncbi.nlm.nih.gov/pubmed/29615488
http://dx.doi.org/10.1136/gutjnl-2017-315783

Ejemplares similares